Aaron M. Sargeant

Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases

Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou et al. · Molecular Pharmacology · 2010 · 111 citations

Medicine, Molecular Biology, Oncology +16

A Potent Indole-3-Carbinol–Derived Antitumor Agent with Pleiotropic Effects on Multiple Signaling Pathways in Prostate Cancer Cells

Jing‐Ru Weng, Chen-Hsun Tsai, Samuel K. Kulp et al. · Cancer Research · 2007 · 76 citations

Medicine, Oncology, Pharmacology +13

OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model

Aaron M. Sargeant, Robert C. Rengel, Samuel K. Kulp et al. · Cancer Research · 2008 · 61 citations

Medicine, Oncology, Pharmacology +13

Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors

Yu-Chieh Wang, Samuel K. Kulp, Dasheng Wang et al. · Cancer Research · 2008 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma

Hany A. Omar, Aaron M. Sargeant, Jing‐Ru Weng et al. · Molecular Pharmacology · 2009 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15